Badran BW, Dowdle LT, Mithoefer OJ et al (2022) Neurophysiologic effects of transcutaneous auricular vagus nerve stimulation (taVNS) via electrical stimulation of the tragus: a concurrent taVNS/fMRI study and review. Focus (Am Psychiatr Publ) 20:80–89
PubMed PubMed Central Google Scholar
Banerjee D, Das PK, Mukherjee J (2023) Nervous system. In: Textbook of veterinary physiology. Springer, Berlin, pp 265–293
Baudendistel ST, Haussler AM, Rawson KS et al (2024) Minimal clinically important differences of spatiotemporal gait variables in Parkinson disease. Gait Posture 108:257–263
Ben-Shlomo Y, Darweesh S, Llibre-Guerra J et al (2024) The epidemiology of Parkinson’s disease. Lancet 403:283–292
Article PubMed PubMed Central Google Scholar
Bohnen NI, Kanel P, Zhou Z et al (2019) Cholinergic system changes of falls and freezing of gait in Parkinson’s disease. Ann Neurol 85:538–549
Article CAS PubMed PubMed Central Google Scholar
Bottomley JM, Lereun C, Diamantopoulos A et al (2020) Vagus nerve stimulation (VNS) therapy in patients with treatment resistant depression: a systematic review and meta-analysis. Compr Psychiatry 98:152156
Braak H, Del Tredici K, Rüb U et al (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211
Broderick L, Tuohy G, Solymos O et al (2023) Management of vagus nerve stimulation therapy in the peri-operative period: guidelines from the Association of Anaesthetists. Anaesthesia 78:747–757
Article CAS PubMed Google Scholar
Buijs RM, Van Eden CG (2000) The integration of stress by the hypothalamus, amygdala and prefrontal cortex: balance between the autonomic nervous system and the neuroendocrine system. In: Progress in brain research. Elsevier, Amsterdam, pp 117–132
Butt MF, Albusoda A, Farmer AD et al (2020) The anatomical basis for transcutaneous auricular vagus nerve stimulation. J Anat 236:588–611
Cheng W, Fang K, Ouyang X et al (2024) Vagus nerve stimulation with a small total charge transfer improves motor behavior and reduces neuroinflammation in a mouse model of Parkinson’s disease. Neurochem Int 180:105871
Article CAS PubMed Google Scholar
Di Biase L, Pecoraro PM, Carbone SP et al (2023) Levodopa-induced dyskinesias in Parkinson’s disease: an overview on pathophysiology, clinical manifestations, therapy management strategies and future directions. J Clin Med 12:4427
Article CAS PubMed PubMed Central Google Scholar
Dolgacheva LP, Zinchenko VP, Goncharov NV (2022) Molecular and cellular interactions in pathogenesis of sporadic Parkinson disease. Int J Mol Sci 23:13043
Article CAS PubMed PubMed Central Google Scholar
Dorsey ER, Elbaz A, Nichols E et al (2018) Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:939–953
Farrand AQ, Helke KL, Aponte-Cofresí L et al (2019) Effects of vagus nerve stimulation are mediated in part by TrkB in a Parkinson’s disease model. Behav Brain Res 373:112080
Article CAS PubMed PubMed Central Google Scholar
Farrand AQ, Helke KL, Gregory RA et al (2017) Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson’s disease. Brain Stimul 10:1045–1054
Article PubMed PubMed Central Google Scholar
Fenu S, Wardas J, Morelli M (2009) Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson’s disease. Behav Pharmacol 20:363–379
Article CAS PubMed Google Scholar
Goetz CG, Tilley BC, Shaftman SR et al (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129–2170
Greene JG (2014) Causes and consequences of degeneration of the dorsal motor nucleus of the vagus nerve in Parkinson’s disease. Antioxid Redox Signal 21:649–667
Article CAS PubMed Google Scholar
Hass CJ, Bishop M, Moscovich M et al (2014) Defining the clinically meaningful difference in gait speed in persons with Parkinson disease. J Neurol Phys Ther 38:233–238
Hilz MJ (2022) Transcutaneous vagus nerve stimulation-a brief introduction and overview. Auton Neurosci 243:103038
Hou X, Watzlawik JO, Fiesel FC et al (2020) Autophagy in Parkinson’s disease. J Mol Biol 432:2651–2672
Article CAS PubMed PubMed Central Google Scholar
Ji Z, Chen Q, Yang J et al (2024) Global, regional, and national health inequalities of Alzheimer’s disease and Parkinson’s disease in 204 countries, 1990–2019. Int J Equity Health 23:125
Article PubMed PubMed Central Google Scholar
Johnson RL, Wilson CG (2018) A review of vagus nerve stimulation as a therapeutic intervention. J Inflamm Res. https://doi.org/10.2147/JIR.S163248
Article PubMed PubMed Central Google Scholar
Kohat AK, Ng SY, Wong AS et al (2021) Stability of MDS-UPDRS motor subtypes over three years in early Parkinson’s disease. Front Neurol 12:704906
Article PubMed PubMed Central Google Scholar
Lampros M, Vlachos N, Zigouris A et al (2021) Transcutaneous vagus nerve stimulation (t-VNS) and epilepsy: a systematic review of the literature. Seizure 91:40–48
Lench DH, Turner TH, Mcleod C et al (2023) Multi-session transcutaneous auricular vagus nerve stimulation for Parkinson’s disease: evaluating feasibility, safety, and preliminary efficacy. Front Neurol. https://doi.org/10.3389/fneur.2023.1210103
Article PubMed PubMed Central Google Scholar
Li Y, Ding S, Wang Y (2025) Targeting the cholinergic anti-inflammatory pathway: an innovative strategy for treating diseases. Mol Biol Rep 52:199
Article CAS PubMed Google Scholar
Liu F-J, Wu J, Gong L-J et al (2024) Non-invasive vagus nerve stimulation in anti-inflammatory therapy: mechanistic insights and future perspectives. Front Neurosci 18:1490300
Article PubMed PubMed Central Google Scholar
Marano M, Anzini G, Musumeci G et al (2022) Transcutaneous auricular vagus stimulation improves gait and reaction time in Parkinson’s disease. Mov Disord 37:2163–2164
Article PubMed PubMed Central Google Scholar
Marano M, Anzini G, Saltarocchi L et al (2024) Left vagus stimulation modulates contralateral subthalamic β power improving the gait in Parkinson’s disease. Mov Disord 39:424–428
Merims D, Giladi N (2008) Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson’s disease. Parkinsonism Relat Disord 14:273–280
Mondal B, Choudhury S, Banerjee R et al (2024) Effects of non-invasive vagus nerve stimulation on clinical symptoms and molecular biomarkers in Parkinson’s disease. Front Aging Neurosci 15:1331575
Article PubMed PubMed Central Google Scholar
Mondal B, Choudhury S, Banerjee R et al. (2024) Effects of non-invasive vagus nerve stimulation on clinical symptoms and molecular biomarkers in Parkinson's disease. Front Aging Neurosci 1–13
Muthukrishnan N, Abbas JJ, Shill HA et al (2019) Cueing paradigms to improve gait and posture in Parkinson’s disease: a narrative review. Sensors 19:5468
Comments (0)